Why Amylyx Pharmaceuticals Blasted Nearly 79% Higher This Week
The biotech delivered excellent news from the laboratory.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
What's breaking now, across thousands of outlets.
The biotech delivered excellent news from the laboratory.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
One turnaround story shows recovery despite revenue headwinds; the other leans on government contracts and strong cash flow. Their valuations tell very different stories.
Bargain hunters are flocking to the discount retailer's stores.
Boda boda riders could pay less for motorcycles bought on credit if Parliament succeeds in extending the in duplum rule to companies that finance motorcycles, potentially shielding borrowers from…
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo